AI Portfolio Summary
In 2025 Q4, Sands Capital Alternatives, LLC maintained a portfolio of 21 distinct positions. The most significant new addition to the portfolio was SERVICETITAN INC, which now represents 1.85% of the total fund value. They heavily accumulated shares in KLAVIYO INC, increasing their position by 3.8%. Conversely, Sands Capital Alternatives, LLC completely exited their position in CROWDSTRIKE HLDGS IN.
Total Positions
21
Quarter
2025 Q4
Top Holding
KVYO (22.9%)
Top 10 Concentration
88.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-21 of 21
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
KVYO
KLAVIYO INC
|
Technology | 22.86% | 21.33% |
#1
1
Prev: #2
|
6.5 | 134,613 | 3.8% |
P
S
|
3,649,678 | $118,505,045 | 2023 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
NU
NU HLDGS LTD
|
Financial Services | 22.15% | 25.17% |
#2
1
Prev: #1
|
6.0 | -314,035 | -4.4% |
P
S
|
6,861,399 | $114,859,819 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 20.98% | 15.54% |
#3
Prev: #3
|
6.0 | no change | no change |
P
S
|
3,570,113 | $108,781,343 | 2025 Q1 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 5.15% | 3.89% |
#4
3
Prev: #7
|
4.6 | 2,068,965 | 18.9% |
P
S
|
13,018,965 | $26,688,878 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DASH
DOORDASH INC
|
Consumer Cyclical | 4.18% | 5.37% |
#5
Prev: #5
|
4.2 | 5,476 | 6.1% |
P
S
|
95,618 | $21,655,565 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CPNG
COUPANG INC
|
Consumer Cyclical | 3.96% | 5.61% |
#6
2
Prev: #4
|
3.6 | 75,418 | 9.5% |
P
S
|
870,424 | $20,533,302 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
IOT
SAMSARA INC
|
Technology | 3.19% | 4.89% |
#7
1
Prev: #6
|
1.3 | -132,724 | -22.2% |
P
S
|
466,190 | $16,526,436 | 2021 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
DDOG
DATADOG INC
|
Technology | 2.25% | 3.70% |
#8
Prev: #8
|
0.9 | -32,914 | -27.7% |
P
S
|
85,793 | $11,666,990 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TOST
TOAST INC
|
Technology | 2.07% | 1.25% |
#9
5
Prev: #14
|
3.8 | 145,043 | 92.6% |
P
S
|
301,647 | $10,711,485 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 2.01% | 1.01% |
#10
6
Prev: #16
|
1.8 | no change | no change |
P
S
|
786,353 | $10,403,450 | 2024 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
MNDY
MONDAY COM LTD
|
Technology | 1.93% | 2.48% |
#11
2
Prev: #9
|
2.8 | 9,532 | 16.3% |
P
S
|
67,868 | $10,014,602 | 2024 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TTAN
SERVICETITAN IN...
|
Technology | 1.85% | — |
#12
Prev: #—
|
4.2 | 89,856 | no change |
NEW
|
89,856 | $9,569,664 | 2025 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 1.52% | 1.23% |
#13
2
Prev: #15
|
1.6 | no change | no change |
P
S
|
481,770 | $7,857,669 | 2022 Q2 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ABOS
ACUMEN PHARMACE...
|
Healthcare | 1.39% | 1.28% |
#14
1
Prev: #13
|
1.6 | no change | no change |
P
S
|
3,417,075 | $7,210,028 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 1.34% | 2.21% |
#15
5
Prev: #10
|
0.5 | -85,000 | -50.0% |
P
S
|
85,000 | $6,959,800 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
ACRV
ACRIVON THERAPE...
|
Healthcare | 0.99% | 0.84% |
#16
1
Prev: #17
|
1.4 | no change | no change |
P
S
|
2,122,605 | $5,115,478 | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
SNOW
SNOWFLAKE INC
|
Technology | 0.86% | 1.33% |
#17
5
Prev: #12
|
0.3 | -6,752 | -25.0% |
P
S
|
20,253 | $4,442,698 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
TSHA
TAYSHA GENE THE...
|
Healthcare | 0.77% | 0.52% |
#18
Prev: #18
|
1.3 | no change | no change |
P
S
|
724,873 | $3,986,802 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CADL
CANDEL THERAPEU...
|
Healthcare | 0.44% | 0.45% |
#19
Prev: #19
|
1.2 | no change | no change |
P
S
|
405,837 | $2,292,979 | 2021 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
FIG
FIGMA INC
|
Technology | 0.13% | 0.21% |
#20
Prev: #20
|
1.1 | no change | no change |
P
S
|
18,286 | $683,348 | 2025 Q3 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) | |||
|
CRWD
CROWDSTRIKE HLD...
|
Technology | 0.00% | 1.68% |
Sold All 😨
(Was: #11) |
0.0 | -15,615 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2025-12-31 | 2026-02-14 (Est.) |
Showing 1-21 of 21 holdings